Prospective multicentre feasibility study of a quality of care indicator for intravenous to oral switch therapy with highly bioavailable antibiotics
- F. M. Buyle
- , S. Metz-Gercek
- , R. Mechtler
- , W. V. Kern
- , H. Robays
- , D. Vogelaers
- , M. J. Struelens
- , on behalf of the Members of the Antibiotic Strategy International (ABS) Quality Indicators Team
No endorsements
This article has not been endorsed yet.
Like this work?
Let others know. Sign in to add your endorsement.